Literature DB >> 6306469

The Hardy-Zuckerman 2-FeSV, a new feline retrovirus with oncogene homology to Abelson-MuLV.

P Besmer, W D Hardy, E E Zuckerman, P Bergold, L Lederman, H W Snyder.   

Abstract

There is substantial evidence that oncogenes (v-onc) of acute transforming retroviruses have been acquired by transduction of cellular genes (c-onc) with retroviruses. Feline leukaemia virus (FeLV)-associated feline fibrosarcomas have proven to be extremely useful for the isolation of acute transforming retroviruses of a mammalian species. Three different v-onc genes have been identified in five acute transforming feline retroviruses. The Susan McDonough feline sarcoma virus (SMFeSV) contains the oncogene fms (ref. 4). The Snyder-Theilen (ST) and Gardner-Arnstein (GA) FeSVs contain the oncogene fes (ref. 4), which is homologous to the oncogene fps of the avian sarcoma viruses FSV, RRCII, PRCIV and 16L (refs 7, 8). The v-onc sequences of the Parodi-Irgens (PI) FeSV have recently been found to be homologous with the v-sis sequences of the simian sarcoma virus. We report here the isolation of another acute transforming feline retrovirus from a naturally occurring feline fibrosarcoma, designated the Hardy-Zuckerman 2 feline sarcoma virus (HZ2-FeSV) and demonstrate that the HZ2-FeSV and Abelson murine leukaemia virus (A-MuLV) have homologous oncogenes.

Entities:  

Mesh:

Year:  1983        PMID: 6306469     DOI: 10.1038/303825a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  22 in total

1.  The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases.

Authors:  G D Kruh; R Perego; T Miki; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.

Authors:  S K Shore; S L Bogart; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  High-frequency transduction of c-erbB in avian leukosis virus-induced erythroblastosis.

Authors:  B D Miles; H L Robinson
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.

Authors:  J L Rohn; A S Lauring; M L Linenberger; J Overbaugh
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert.

Authors:  P J Bergold; J A Blumenthal; E D'Andrea; H W Snyder; L Lederman; A Silverstone; H Nguyen; P Besmer
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells.

Authors:  L Bonham; P A Lobelle-Rich; L A Henderson; L S Levy
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

7.  Nucleotide sequence of a transduced myc gene from a defective feline leukemia provirus.

Authors:  M J Braun; P L Deininger; J W Casey
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

8.  Nucleotide sequence of avian carcinoma virus MH2: two potential onc genes, one related to avian virus MC29 and the other related to murine sarcoma virus 3611.

Authors:  N C Kan; C S Flordellis; G E Mark; P H Duesberg; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Chromosomal localization and characterization of c-abl in the t(6;9) of acute nonlymphocytic leukemia.

Authors:  C A Westbrook; M M Le Beau; M O Diaz; J Groffen; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.

Authors:  J B Konopka; S M Watanabe; J W Singer; S J Collins; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.